Welcome to our dedicated page for Inuvo SEC filings (Ticker: INUV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inuvo, Inc. filings document an AI-driven advertising technology issuer, its common stock, governance matters and material corporate events. Recent Form 8-K disclosures cover results of operations, preliminary revenue information, convertible-note financing and registration rights, settlement proceeds, executive appointments, and amendments to service agreements involving its Vertro subsidiary.
Inuvo proxy materials describe annual meeting voting matters, including director elections and ratification of the independent registered public accounting firm. The filing record also documents common-stock issuance limits under NYSE American rules, exhibits for material agreements, Regulation FD updates, and operating disclosures tied to IntentKey, Platform activity and digital advertising technology.
Inuvo, Inc. has released an updated investor presentation outlining its IntentKey® AI strategy, market opportunity, and path to long-term value creation. The presentation explains how IntentKey, a proprietary large language model for media decisioning, operates without cookies or personal identifiers, focusing instead on why consumers are interested in products and brands.
Highlights include the accelerating disruption of the programmatic advertising market, IntentKey’s 24-hour lead on emerging consumer demand, dynamic audience model creation, and recent commercial, product, and strategic milestones. Inuvo also details four strategic growth pillars and a path to profitability centered on high-margin IntentKey revenue within a stated $220 billion total addressable market.
Partalo Sanja reported acquisition or exercise transactions in this Form 4 filing.
Inuvo, Inc. director Sanja Partalo reported receiving a grant of restricted stock units. On July 1, 2026, Partalo was awarded 30,702 restricted stock units, each representing a contingent right to receive one share of Inuvo common stock. The award was reported at a price of $0.00 per unit, reflecting that it is a compensation grant rather than a market purchase. Following this grant, Partalo holds 30,702 restricted stock units directly, all tied to Inuvo common shares.
Inuvo, Inc. director Sanja Partalo filed an initial Form 3 insider report that lists no stock purchase, sale, or other reportable transactions. The accompanying data show zero buy, sell, acquire, or dispose entries, so this filing mainly establishes Partalo’s status as a reporting insider.
Inuvo, Inc. director Richard K. Howe reported routine equity compensation activity involving common stock and restricted stock units. On July 1, 2026, he exercised 7,500 restricted stock units into the same number of common shares and had 3,112 shares withheld at $1.14 per share to cover tax obligations, which is not an open-market sale.
He also received a new grant of 30,702 restricted stock units, each representing a contingent right to one share of common stock. Following these transactions, Howe directly held 555,416 common shares and 30,702 restricted stock units. The filing reflects compensation and tax mechanics rather than discretionary buying or selling.
Cameron Gordon J reported acquisition or exercise transactions in this Form 4 filing.
Inuvo, Inc. director Cameron J. Gordon received a grant of 30,702 restricted stock units. The award was made as a compensation grant on July 1, 2026 and carries a price of $0.00 per unit. Each restricted stock unit represents a contingent right to receive one share of Inuvo’s common stock. Following this grant, Gordon holds 30,702 restricted stock units directly.
Bond Jonathan reported acquisition or exercise transactions in this Form 4 filing.
Inuvo, Inc. director Jonathan Bond reported receiving a grant of 30,702 restricted stock units. Each unit represents a contingent right to receive one share of Inuvo common stock, so the award covers 30,702 underlying shares. Following this compensation grant, his reported derivative holdings total 30,702 units.
Inuvo, Inc. strengthened its balance sheet with financing transactions totaling $12.97 million, providing working capital while retiring existing debt. The company issued two secured promissory notes for $10 million in aggregate gross proceeds, using these funds to repay approximately $2.8 million of outstanding convertible promissory notes, including accrued interest, and to terminate its receivables-based credit facility.
Inuvo also agreed to a registered direct offering of 2.97 million shares of common stock (or equivalents) at $1.00 per share, for expected gross proceeds of about $2.97 million, alongside a concurrent private placement of Class A and Class B warrants to purchase up to a total of 5.94 million shares at an exercise price of $1.28 per share.
Inuvo, Inc. is offering 1,631,121 shares of common stock at $1.00 per share and, in lieu of some shares, pre-funded warrants to purchase up to 1,337,693 shares at $0.999 per warrant. The company also completed a concurrent private placement of warrants to purchase up to 5,937,628 shares, divided into Class A and Class B Warrants.
The offering is being conducted with Ladenburg Thalmann as placement agent on a best-efforts basis. Net proceeds to the company before expenses are approximately $2.6 million, and the company states proceeds will be used for working capital. The placement agent will receive fees and placement agent warrants; certain insiders are subject to lock-ups.
INUV suspends its at-the-market (ATM) offering and terminates continuous sales effective June 30, 2026. The prospectus supplement states the company may offer and sell common stock having an aggregate offering price of up to $15,000,000 under the Offering Agreement with H.C. Wainwright.
The supplement reports the company has sold 165,641 shares through the sales agent, generating $1,184,740 in gross proceeds to date. The supplement also states the last reported sale price was $1.36 per share on June 29, 2026. The Offering Agreement remains in full force and effect, but no sales will occur under it unless a new prospectus supplement is filed.
Inuvo, Inc. reported the results of its 2026 annual meeting of stockholders. The meeting was held on June 18, 2026, with a record date of April 21, 2026, when 14,820,898 shares of common stock were outstanding and entitled to vote. A quorum was present, with 7,355,522 shares, or 49.63% of eligible shares, represented in person or by proxy.
Stockholders elected Class III directors Rob Buchner and Sanja Partalo to terms expiring at the 2029 annual meeting. Buchner received 3,697,305 votes for and 118,215 withheld, and Partalo received 3,693,236 votes for and 122,284 withheld; each had 3,540,002 broker non-votes. Stockholders also approved the ratification of EisnerAmper LLP as Inuvo’s independent registered public accounting firm, with 7,046,451 votes for, 297,634 against, 11,437 abstentions, and no broker non-votes.